Educational Session : How Real-World Evidence Can Improve Clinical Trial Productivity

okt 18, 2018: 1:45 p.m. - 2:40 p.m.
California West

As a greater percentage of health care records are digitized, plus with the emergence of patient-provided data sets via wearables and other devices, therapy developers have much greater ability to distill insights from existing data rather than solely relying upon %u201Cstarted from scratch%u201D clinical trials to learn about a disease. Companies are combining new analytical techniques with careful human screening of real world data sources such as electronic health records, insurance billing records, and patients%u2019 mobile devices to develop real-world evidence regarding which patient populations might respond best to a new treatment under development and which diagnostic markers might streamline clinical trial recruitment. In the light of the FDA%u2019s new guidance on real-world evidence this panel will explain how traditional approaches to clinical trial design may be enhanced to save time and money, while improving productivity and outcomes for patients.%uFFFD


Ken Carson
Senior Medical Director

Cartier Esham
Executive Vice Preside...

Gracie Lieberman
Director of Regulatory...

Jeremy Rassen
Co-Founder, President ...

Komathi Stem
Founder and CEO